Skip to content

RNTX RNTX Total debt

Discontinued — last reported Q4 '23

Total debt at other companies

Ethos Technologies, Inc.
 logo
Ethos Technologies, Inc. LIFE
$12.3M-9.2%
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
$823K-48.1%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$350.49M+4.2%
Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
Gilead Sciences logo
Gilead SciencesGILD
AbbVie logo
AbbVieABBV

Other financials

Income statement

See full
Revenue-
Operating income-$5.2M+6.8%
Net income-$5.8M-6.1%
EPS (diluted)-$0.19+24.0%

Balance sheet

See full
Cash & equivalents$4.4M-40.2%
Total equity$6.9M-63.0%
Total assets$26.3M-54.4%

Cash flow

See full
Operating cash flow-$3.4M+44.6%
CapEx-
Free cash flow-$6.3M

Valuation

See full
Market cap$88.96M+177%

Returns & leverage

See full
Return on equity-123.3%+86.1pp
Debt / equity0.0×
Current ratio0.4×-1.0×

Where this comes from

Computed from long term debt + current portion long term debt + short term borrowings + operating lease liabilities + finance lease liabilities + financing obligations: $48K.

The official record: RNTX’s 10-K, filed April 7, 2025, on SEC EDGAR. View the filing →

Ask your AI about RNTX's total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is RNTX's total debt?
RNTX (RNTX) reported total debt of $48K in Q4 2023.
How has RNTX's total debt changed year-over-year?
RNTX's total debt decreased by 0.0% year-over-year, from $48K to $48K.
What is the long-term trend for RNTX's total debt?
Over 2 years (2021 to 2023), RNTX's total debt has grown at a -45.6% compound annual growth rate (CAGR), from $162K to $48K.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.